Health
Alnylam Stands by Heart Disease Treatments Amid AstraZeneca Trial Setback
By Editor • August 30, 2026 • 1 min read
Alnylam Pharmaceuticals defends its heart disease drugs after AstraZeneca's failed trial raises concerns about the efficacy of silencers.
Read more